Skip to main content
Top
Published in: Inflammation 6/2016

01-12-2016 | ORIGINAL ARTICLE

Effect of Phospholipid Transfer Protein on Cigarette Smoke Extract-Induced IL-8 Production in Human Pulmonary Epithelial Cells

Authors: Youlun Li, Xiuying Yu, Xiaofeng Fu, Fengping Wu, Linlin Zou, Yuhan Chen, Yajuan Chen

Published in: Inflammation | Issue 6/2016

Login to get access

Abstract

To investigate the effect of phospholipid transfer protein (PLTP) on the cigarette smoke extract (CSE)-induced production of interleukin-8 (IL-8) in human pulmonary epithelial cells, male Wistar rats were exposed to air and cigarette smoke (n = 10/exposure) for 6 h/day on three consecutive days. Their lungs were sectioned and bronchoalveolar lavage fluid (BALF) examined. The expression of PLTP and IL-8 in the lung was detected immunohistochemically. Lung injury was accompanied by the upregulation of PLTP and IL-8 in the CSE-exposed rat model, and the number of white blood cells in the BALF was significantly increased compared with those of the controls. Both neutrophils and macrophages were clearly increased. Human alveolar epithelial cells (A549) and human bronchial epithelial cells (HBECs) were treated with different concentrations of CSE for various times. The cells were also transfected with small interfering RNA directed against PLTP, and U0126, an inhibitor of the ERK1/2 pathway, was administered before CSE exposure. The expression of PLTP and IL-8 mRNAs and PLTP, IL-8, total ERK, and phosphorylated ERK proteins was analyzed. The expression of IL-8 and phosphorylated ERK was significantly increased in A549 cells and HBECs after CSE stimulation, and CSE upregulated the expression of PLTP in A549 cells. In contrast, CSE inhibited the expression of PLTP in HBECs. The CSE-induced expression of IL-8 and p-ERK was significantly increased by the knockdown of PLTP. Therefore, PLTP may regulate CSE-induced IL-8 expression via the ERK1/2 signaling pathway in human pulmonary epithelial cells.
Literature
1.
go back to reference Borgerding, M., and H. Klus. 2005. Analysis of complex mixtures—cigarette smoke. Experimental and Toxicologic Pathology 57(Suppl 1): 43–73.CrossRefPubMed Borgerding, M., and H. Klus. 2005. Analysis of complex mixtures—cigarette smoke. Experimental and Toxicologic Pathology 57(Suppl 1): 43–73.CrossRefPubMed
2.
go back to reference Cunningham, F.H., S. Fiebelkorn, M. Johnson, and C. Meredith. 2011. A novel application of the margin of exposure approach: segregation of tobacco smoke toxicants. Food and Chemical Toxicology 49: 2921–2933.CrossRefPubMed Cunningham, F.H., S. Fiebelkorn, M. Johnson, and C. Meredith. 2011. A novel application of the margin of exposure approach: segregation of tobacco smoke toxicants. Food and Chemical Toxicology 49: 2921–2933.CrossRefPubMed
3.
go back to reference Sangani, R.G., and A.J. Ghio. 2011. Lung injury after cigarette smoking is particle related. International Journal of Chronic Obstructive Pulmonary Disease 6: 191–198.PubMedPubMedCentral Sangani, R.G., and A.J. Ghio. 2011. Lung injury after cigarette smoking is particle related. International Journal of Chronic Obstructive Pulmonary Disease 6: 191–198.PubMedPubMedCentral
4.
go back to reference Tandon, S., A. Batchelor, R. Bullock, A. Gascoigne, M. Griffin, N. Hayes, et al. 2001. Peri-operative risk factors for acute lung injury after elective oesophagectomy. British Journal of Anaesthesia 86: 633–638.CrossRefPubMed Tandon, S., A. Batchelor, R. Bullock, A. Gascoigne, M. Griffin, N. Hayes, et al. 2001. Peri-operative risk factors for acute lung injury after elective oesophagectomy. British Journal of Anaesthesia 86: 633–638.CrossRefPubMed
5.
go back to reference Wewers, M.E., A. Munzer, and G. Ewart. 2010. Tackling a root cause of chronic lung disease: the ATS, FDA, and tobacco control. American Journal of Respiratory and Critical Care Medicine 181: 1281–1282.CrossRefPubMed Wewers, M.E., A. Munzer, and G. Ewart. 2010. Tackling a root cause of chronic lung disease: the ATS, FDA, and tobacco control. American Journal of Respiratory and Critical Care Medicine 181: 1281–1282.CrossRefPubMed
6.
go back to reference Rojas, M., and A.L. Mora. 2011. Age and smoke: a risky combination. American Journal of Respiratory and Critical Care Medicine 183: 423–424.CrossRefPubMed Rojas, M., and A.L. Mora. 2011. Age and smoke: a risky combination. American Journal of Respiratory and Critical Care Medicine 183: 423–424.CrossRefPubMed
7.
go back to reference Hecht, S.S., and E. Szabo. 2014. Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer. Cancer Prevention Research (Philadelphia, Pa.) 7: 1–8.CrossRef Hecht, S.S., and E. Szabo. 2014. Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer. Cancer Prevention Research (Philadelphia, Pa.) 7: 1–8.CrossRef
8.
go back to reference Chen, M., T. Yang, X. Meng, and T. Sun. 2015. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. Molecular Medicine Reports 11: 3414–3422.PubMedPubMedCentral Chen, M., T. Yang, X. Meng, and T. Sun. 2015. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. Molecular Medicine Reports 11: 3414–3422.PubMedPubMedCentral
9.
go back to reference Wang, Y., Y. Zhu, S. Xing, P. Ma, and D. Lin. 2015. SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3. Cell Stress & Chaperones 20: 805–810.CrossRef Wang, Y., Y. Zhu, S. Xing, P. Ma, and D. Lin. 2015. SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3. Cell Stress & Chaperones 20: 805–810.CrossRef
10.
go back to reference Chen, H., K. Liao, L. Cui-Zhao, F. Qiang-Wen, X. Feng-Zeng, F. Ping-Wu, et al. 2015. Cigarette smoke extract induces apoptosis of rat alveolar type II cells via the PLTP/TGF-beta1/Smad2 pathway. International Immunopharmacology 28: 707–714.CrossRefPubMed Chen, H., K. Liao, L. Cui-Zhao, F. Qiang-Wen, X. Feng-Zeng, F. Ping-Wu, et al. 2015. Cigarette smoke extract induces apoptosis of rat alveolar type II cells via the PLTP/TGF-beta1/Smad2 pathway. International Immunopharmacology 28: 707–714.CrossRefPubMed
11.
go back to reference de Vries, M., I.H. Heijink, R. Gras, L.E. den Boef, M. Reinders-Luinge, S.D. Pouwels, et al. 2014. Pim1 kinase protects airway epithelial cells from cigarette smoke-induced damage and airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 307: L240–251.CrossRefPubMed de Vries, M., I.H. Heijink, R. Gras, L.E. den Boef, M. Reinders-Luinge, S.D. Pouwels, et al. 2014. Pim1 kinase protects airway epithelial cells from cigarette smoke-induced damage and airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 307: L240–251.CrossRefPubMed
12.
go back to reference Mortaz, E., P.A. Henricks, A.D. Kraneveld, M.E. Givi, J. Garssen, and G. Folkerts. 2011. Cigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells via TLRs and induction of the inflammasome. Biochimica et Biophysica Acta 1812: 1104–1110.CrossRefPubMed Mortaz, E., P.A. Henricks, A.D. Kraneveld, M.E. Givi, J. Garssen, and G. Folkerts. 2011. Cigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells via TLRs and induction of the inflammasome. Biochimica et Biophysica Acta 1812: 1104–1110.CrossRefPubMed
13.
go back to reference Witherden, I.R., E.J. Vanden Bon, P. Goldstraw, C. Ratcliffe, U. Pastorino, and T.D. Tetley. 2004. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. American Journal of Respiratory Cell and Molecular Biology 30: 500–509.CrossRefPubMed Witherden, I.R., E.J. Vanden Bon, P. Goldstraw, C. Ratcliffe, U. Pastorino, and T.D. Tetley. 2004. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. American Journal of Respiratory Cell and Molecular Biology 30: 500–509.CrossRefPubMed
14.
go back to reference Mio, T., D.J. Romberger, A.B. Thompson, R.A. Robbins, A. Heires, and S.I. Rennard. 1997. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. American Journal of Respiratory and Critical Care Medicine 155: 1770–1776.CrossRefPubMed Mio, T., D.J. Romberger, A.B. Thompson, R.A. Robbins, A. Heires, and S.I. Rennard. 1997. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. American Journal of Respiratory and Critical Care Medicine 155: 1770–1776.CrossRefPubMed
15.
go back to reference Moretto, N., F. Facchinetti, T. Southworth, M. Civelli, D. Singh, and R. Patacchini. 2009. alpha, beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. American Journal of Physiology. Lung Cellular and Molecular Physiology 296: L839–848.CrossRefPubMed Moretto, N., F. Facchinetti, T. Southworth, M. Civelli, D. Singh, and R. Patacchini. 2009. alpha, beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. American Journal of Physiology. Lung Cellular and Molecular Physiology 296: L839–848.CrossRefPubMed
16.
go back to reference Fuke, S., T. Betsuyaku, Y. Nasuhara, T. Morikawa, H. Katoh, and M. Nishimura. 2004. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 31: 405–412.CrossRefPubMed Fuke, S., T. Betsuyaku, Y. Nasuhara, T. Morikawa, H. Katoh, and M. Nishimura. 2004. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 31: 405–412.CrossRefPubMed
17.
go back to reference Pease, J.E., and I. Sabroe. 2002. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. American Journal of Respiratory Medicine 1: 19–25.CrossRefPubMed Pease, J.E., and I. Sabroe. 2002. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. American Journal of Respiratory Medicine 1: 19–25.CrossRefPubMed
18.
go back to reference Pugin, J., G. Verghese, M.C. Widmer, and M.A. Matthay. 1999. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Critical Care Medicine 27: 304–312.CrossRefPubMed Pugin, J., G. Verghese, M.C. Widmer, and M.A. Matthay. 1999. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Critical Care Medicine 27: 304–312.CrossRefPubMed
19.
go back to reference Li, F.F., J. Shen, H.J. Shen, X. Zhang, R. Cao, Y. Zhang, et al. 2012. Shp2 plays an important role in acute cigarette smoke-mediated lung inflammation. Journal of Immunology 189: 3159–3167.CrossRef Li, F.F., J. Shen, H.J. Shen, X. Zhang, R. Cao, Y. Zhang, et al. 2012. Shp2 plays an important role in acute cigarette smoke-mediated lung inflammation. Journal of Immunology 189: 3159–3167.CrossRef
20.
go back to reference Wolfbauer, G., J.J. Albers, and J.F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochimica et Biophysica Acta 1439: 65–76.CrossRefPubMed Wolfbauer, G., J.J. Albers, and J.F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochimica et Biophysica Acta 1439: 65–76.CrossRefPubMed
21.
go back to reference Albers, J.J., S. Vuletic, and M.C. Cheung. 2012. Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochimica et Biophysica Acta 1821: 345–357.CrossRefPubMed Albers, J.J., S. Vuletic, and M.C. Cheung. 2012. Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochimica et Biophysica Acta 1821: 345–357.CrossRefPubMed
22.
go back to reference Vuletic, S., W. Dong, G. Wolfbauer, C. Tang, and J.J. Albers. 2011. PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages. Biochimica et Biophysica Acta 1813: 1917–1924.CrossRefPubMedPubMedCentral Vuletic, S., W. Dong, G. Wolfbauer, C. Tang, and J.J. Albers. 2011. PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages. Biochimica et Biophysica Acta 1813: 1917–1924.CrossRefPubMedPubMedCentral
23.
go back to reference Wehinger, A., I. Tancevski, W. Schgoer, P. Eller, K. Hochegger, M. Morak, et al. 2007. Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 908–915.CrossRefPubMed Wehinger, A., I. Tancevski, W. Schgoer, P. Eller, K. Hochegger, M. Morak, et al. 2007. Phospholipid transfer protein augments apoptosis in THP-1-derived macrophages induced by lipolyzed hypertriglyceridemic plasma. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 908–915.CrossRefPubMed
24.
go back to reference Cheung, M.C., B.G. Brown, E.K. Marino Larsen, A.D. Frutkin, K.D. O’Brien, and J.J. Albers. 2006. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochimica et Biophysica Acta 1762: 131–137.CrossRefPubMed Cheung, M.C., B.G. Brown, E.K. Marino Larsen, A.D. Frutkin, K.D. O’Brien, and J.J. Albers. 2006. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochimica et Biophysica Acta 1762: 131–137.CrossRefPubMed
25.
go back to reference Cavusoglu, E., J.D. Marmur, S. Chhabra, M.R. Hojjati, S. Yanamadala, V. Chopra, et al. 2015. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease. Atherosclerosis 239: 503–508.CrossRefPubMedPubMedCentral Cavusoglu, E., J.D. Marmur, S. Chhabra, M.R. Hojjati, S. Yanamadala, V. Chopra, et al. 2015. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease. Atherosclerosis 239: 503–508.CrossRefPubMedPubMedCentral
26.
go back to reference Vuletic, S., E.R. Peskind, S.M. Marcovina, J.F. Quinn, M.C. Cheung, H. Kennedy, et al. 2005. Reduced CSF PLTP activity in Alzheimer’s disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. Journal of Neuroscience Research 80: 406–413.CrossRefPubMed Vuletic, S., E.R. Peskind, S.M. Marcovina, J.F. Quinn, M.C. Cheung, H. Kennedy, et al. 2005. Reduced CSF PLTP activity in Alzheimer’s disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. Journal of Neuroscience Research 80: 406–413.CrossRefPubMed
27.
go back to reference Jiang, X.C., J. D’Armiento, R.K. Mallampalli, J. Mar, S.F. Yan, and M. Lin. 1998. Expression of plasma phospholipid transfer protein mRNA in normal and emphysematous lungs and regulation by hypoxia. The Journal of Biological Chemistry 273: 15714–15718.CrossRefPubMed Jiang, X.C., J. D’Armiento, R.K. Mallampalli, J. Mar, S.F. Yan, and M. Lin. 1998. Expression of plasma phospholipid transfer protein mRNA in normal and emphysematous lungs and regulation by hypoxia. The Journal of Biological Chemistry 273: 15714–15718.CrossRefPubMed
28.
go back to reference Dullaart, R.P., K. Hoogenberg, B.D. Dikkeschei, and A. van Tol. 1994. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arteriosclerosis and Thrombosis 14: 1581–1585.CrossRefPubMed Dullaart, R.P., K. Hoogenberg, B.D. Dikkeschei, and A. van Tol. 1994. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arteriosclerosis and Thrombosis 14: 1581–1585.CrossRefPubMed
29.
go back to reference Guo, L.L., Y.J. Chen, T. Wang, J. An, C.N. Wang, Y.C. Shen, et al. 2012. Ox-LDL-induced TGF-beta1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway. Journal of Cellular Physiology 227: 3185–3191.CrossRefPubMed Guo, L.L., Y.J. Chen, T. Wang, J. An, C.N. Wang, Y.C. Shen, et al. 2012. Ox-LDL-induced TGF-beta1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway. Journal of Cellular Physiology 227: 3185–3191.CrossRefPubMed
30.
go back to reference Profita, M., A. Bonanno, L. Siena, M. Ferraro, A.M. Montalbano, F. Pompeo, et al. 2008. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. European Journal of Pharmacology 582: 145–153.CrossRefPubMed Profita, M., A. Bonanno, L. Siena, M. Ferraro, A.M. Montalbano, F. Pompeo, et al. 2008. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism. European Journal of Pharmacology 582: 145–153.CrossRefPubMed
31.
go back to reference Brehm, A., P. Geraghty, M. Campos, I. Garcia-Arcos, A.J. Dabo, A. Gaffney, et al. 2014. Cathepsin G degradation of phospholipid transfer protein (PLTP) augments pulmonary inflammation. The FASEB Journal 28: 2318–2331.CrossRefPubMedPubMedCentral Brehm, A., P. Geraghty, M. Campos, I. Garcia-Arcos, A.J. Dabo, A. Gaffney, et al. 2014. Cathepsin G degradation of phospholipid transfer protein (PLTP) augments pulmonary inflammation. The FASEB Journal 28: 2318–2331.CrossRefPubMedPubMedCentral
32.
go back to reference Ghio, A.J., E.D. Hilborn, J.G. Stonehuerner, L.A. Dailey, J.D. Carter, J.H. Richards, et al. 2008. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. American Journal of Respiratory and Critical Care Medicine 178: 1130–1138.CrossRefPubMed Ghio, A.J., E.D. Hilborn, J.G. Stonehuerner, L.A. Dailey, J.D. Carter, J.H. Richards, et al. 2008. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. American Journal of Respiratory and Critical Care Medicine 178: 1130–1138.CrossRefPubMed
33.
go back to reference Wirtz, H.R., and M. Schmidt. 1996. Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. The European Respiratory Journal 9: 24–32.CrossRefPubMed Wirtz, H.R., and M. Schmidt. 1996. Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. The European Respiratory Journal 9: 24–32.CrossRefPubMed
34.
go back to reference Tang, G.J., H.Y. Wang, J.Y. Wang, C.C. Lee, H.W. Tseng, Y.L. Wu, et al. 2011. Novel role of AMP-activated protein kinase signaling in cigarette smoke induction of IL-8 in human lung epithelial cells and lung inflammation in mice. Free Radical Biology & Medicine 50: 1492–1502.CrossRef Tang, G.J., H.Y. Wang, J.Y. Wang, C.C. Lee, H.W. Tseng, Y.L. Wu, et al. 2011. Novel role of AMP-activated protein kinase signaling in cigarette smoke induction of IL-8 in human lung epithelial cells and lung inflammation in mice. Free Radical Biology & Medicine 50: 1492–1502.CrossRef
35.
go back to reference Mortaz, E., M.V. Rad, M. Johnson, D. Raats, F.P. Nijkamp, and G. Folkerts. 2008. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke. Journal of Molecular Medicine (Berl) 86: 1045–1056.CrossRef Mortaz, E., M.V. Rad, M. Johnson, D. Raats, F.P. Nijkamp, and G. Folkerts. 2008. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke. Journal of Molecular Medicine (Berl) 86: 1045–1056.CrossRef
36.
go back to reference Gautier, T., A. Klein, V. Deckert, C. Desrumaux, N. Ogier, A.L. Sberna, et al. 2008. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. The Journal of Biological Chemistry 283: 18702–18710.CrossRefPubMed Gautier, T., A. Klein, V. Deckert, C. Desrumaux, N. Ogier, A.L. Sberna, et al. 2008. Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice. The Journal of Biological Chemistry 283: 18702–18710.CrossRefPubMed
37.
go back to reference Schlitt, A., J. Liu, D. Yan, M. Mondragon-Escorpizo, A.J. Norin, and X.C. Jiang. 2005. Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice. Biochimica et Biophysica Acta 1733: 187–191.CrossRefPubMed Schlitt, A., J. Liu, D. Yan, M. Mondragon-Escorpizo, A.J. Norin, and X.C. Jiang. 2005. Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice. Biochimica et Biophysica Acta 1733: 187–191.CrossRefPubMed
Metadata
Title
Effect of Phospholipid Transfer Protein on Cigarette Smoke Extract-Induced IL-8 Production in Human Pulmonary Epithelial Cells
Authors
Youlun Li
Xiuying Yu
Xiaofeng Fu
Fengping Wu
Linlin Zou
Yuhan Chen
Yajuan Chen
Publication date
01-12-2016
Publisher
Springer US
Published in
Inflammation / Issue 6/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0432-1

Other articles of this Issue 6/2016

Inflammation 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.